1. Home
  2. IOVA vs NCMI Comparison

IOVA vs NCMI Comparison

Compare IOVA & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.88

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$3.91

Market Cap

414.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
NCMI
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
968.6M
414.7M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
IOVA
NCMI
Price
$2.88
$3.91
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$10.45
$6.88
AVG Volume (30 Days)
11.3M
410.4K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
3.05%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,425,000.00
$236,300,000.00
Revenue This Year
$60.71
$3.66
Revenue Next Year
$59.52
$12.17
P/E Ratio
N/A
N/A
Revenue Growth
175.62
N/A
52 Week Low
$1.64
$3.81
52 Week High
$8.15
$7.25

Technical Indicators

Market Signals
Indicator
IOVA
NCMI
Relative Strength Index (RSI) 68.95 40.26
Support Level $2.08 $3.84
Resistance Level $2.60 $4.00
Average True Range (ATR) 0.17 0.12
MACD 0.07 -0.02
Stochastic Oscillator 86.80 18.29

Price Performance

Historical Comparison
IOVA
NCMI

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: